Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016935
Filing Date
2022-08-11
Accepted
2022-08-11 17:01:44
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-20220630.htm   iXBRL 10-Q 1997120
2 EX-10.1 eldn-ex10_1.htm EX-10.1 480937
3 EX-10.2 eldn-ex10_2.htm EX-10.2 69971
4 EX-10.3 eldn-ex10_3.htm EX-10.3 361220
5 EX-31.1 eldn-ex31_1.htm EX-31.1 18745
6 EX-31.2 eldn-ex31_2.htm EX-31.2 19125
7 EX-32.1 eldn-ex32_1.htm EX-32.1 12663
8 EX-32.2 eldn-ex32_2.htm EX-32.2 12895
  Complete submission text file 0000950170-22-016935.txt   6909147

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20220630.xsd EX-101.SCH 37163
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20220630_pre.xml EX-101.PRE 195719
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eldn-20220630_def.xml EX-101.DEF 112547
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20220630_lab.xml EX-101.LAB 267756
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eldn-20220630_cal.xml EX-101.CAL 29545
46 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20220630_htm.xml XML 968178
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 221156800
SIC: 2834 Pharmaceutical Preparations